pancreatic carcinoma
Conditions
Interventions
Anamorelin 100 mg/day, upon waking Elental 600 kcal/day These will be administered for 12 weeks and evaluated. After 13 weeks, patients will be followed up with or without medication until the fina
Sponsors
Osaka Medical and Pharmaceutical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with pancreatic cancer complicated with pre-cachexia or cachexia who are undergoing treatment at our hospital. Patients must be between 20 and 95 years of age at the time of enrollment. Written consent for participation in the study has been obtained from the subjects themselves.
Exclusion criteria
Exclusion criteria: Patients with a history of other cancers, and who have been treated for these cancers within 1 year. Patients with liver disease Cases in which the patient is pregnant, under 20 years of age, or unable to give consent Cases in which the patient has requested to withdraw consent by disclosing information. Other research subjects whom the principal investigator or physician in charge deems inappropriate for the safe implementation of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| muscle mass:On CT images, the total skeletal muscle mass at the level of the third lumbar vertebrae is measured using SYNAPSE VINCENT. | — |
Secondary
| Measure | Time frame |
|---|---|
| STAS,weight gain,grip strength | — |
Countries
Japan
Contacts
Public ContactAtsushi Okuda
Osaka Medical and Pharmaceutical University 2nd Department of Internal Medicine
Outcome results
None listed